Last updated: June 2026. CJC-1295 has no FDA approval. Nothing here is for sale, and nothing here is medical advice. It’s meant to help you understand the choice in front of you before you make it.
Picture the moment. It’s late, maybe a Tuesday, and someone’s been reading about growth hormone peptides for an hour with a browser tab open to a checkout page. A vial, a price, an “add to cart” button. That single click is where most people’s understanding of CJC-1295 starts and ends, and it’s the part of this story worth slowing down on, because that click is not the only door into this compound. There’s another one, and the two lead to genuinely different places.
This piece is for anyone who has typed “buy CJC-1295 online” into a search bar this year, whether they’re chasing better recovery, curious about growth hormone, or just trying to make sense of what’s floating around the peptide world. It’s written for the person who wants the honest version before spending money, not after.
Who this matters to
If you’ve been reading about CJC-1295 in a gym forum or a biohacker group chat, you’ve probably absorbed the idea that “buying it online” is one thing, a single lane. It isn’t. There’s the gray market, a research-chemical site where you check a box saying the product is “not for human consumption” and a padded envelope shows up with no clinician anywhere near the transaction. And there’s supervised telehealth, where a licensed prescriber reviews your history first and a licensed pharmacy handles the actual compounding.
Same molecule, nominally. Completely different amount of accountability standing between you and the needle. That distinction is the whole reason this page exists, and it’s worth sitting with before we get into the science.
What the science actually says
Here’s the part that deserves patience rather than a scroll-past.
CJC-1295 was built to mimic growth hormone-releasing hormone, nudging the pituitary gland to put out more growth hormone. It was originally meant to help with muscle-wasting conditions. It never crossed the finish line to FDA approval. What we do know from human research comes from one published study: a single dose raised growth hormone two- to ten-fold for six or more days, and IGF-1 one-and-a-half to three-fold for nine to eleven days, in healthy adults who tolerated it reasonably well [P1]. That’s real data. It’s also the extent of the human pharmacology evidence, one study, not a body of trials.
The larger trial tells a harder story, and it’s the one gray-market sellers never mention. ConjuChem ran a Phase II study of CJC-1295 (the DAC version) in 192 people with HIV-related fat accumulation. It was stopped in July 2006, after a participant died following his eleventh weekly injection [P2]. Read that again slowly: ten injections in, nothing unusual. The eleventh is where things went wrong. The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease, unrelated to the compound, and a competing GRF drug’s trial was allowed to continue [P3][P2]. That’s not proof CJC-1295 is dangerous. It is proof that something worth catching in advance, a cardiac risk factor sitting quietly in someone’s chart, can matter enormously with a compound like this, and that the only person positioned to catch it is a clinician who’s actually looked at your history. A shopping cart cannot ask you about your heart.
Now overlay that with what April 2026 reporting found across the unregulated peptide trade more broadly: injectable products carrying impurities including bacteria or heavy metals, immune reactions ranging from mild to life-threatening, and a documented case of two women becoming critically ill after receiving FDA-flagged peptides at a 2025 event [P4]. That same reporting placed CJC-1295, by name, in the FDA’s Category 2, the bucket for compounds flagged with potential safety concerns [P4]. A seller’s certificate of analysis, when one exists at all, describes a sample the company chose to test, not necessarily your vial, and it typically checks identity rather than the sterility and endotoxin screening that actually protects you when something’s going into your bloodstream.
And if you’re a tested athlete, there’s a flatly non-negotiable piece here too. The WADA 2026 Prohibited List names CJC-1295 explicitly, under section S2.2.4, as a prohibited growth-hormone-releasing factor, banned at all times, in and out of competition [P5]. A “research use only” sticker offers zero protection there. If you compete, this is a hard stop, full stop, and worth double-checking against the current list before going anywhere near it.
How to go about it, if you’re going to look into it at all
If safety is genuinely the priority, the honest answer is that there’s no way to buy unregulated, research-chemical CJC-1295 safely. Not a cleaner vendor, not a better-reviewed website. The structural problem, no clinician, no pharmacy, no accountability, doesn’t go away because a site looks polished.
The safer path is supervised telehealth, and here’s how the landscape actually sorts out:
| Where | Type | Clinician in the loop? | How it reaches you | Safer route? |
|---|---|---|---|---|
| FormBlends | Licensed telehealth provider | Yes, prescription required | Compounded and dispensed by a licensed pharmacy | Yes |
| HealthRX.com (healthrx.com) | Licensed telehealth provider | Yes, prescription required | Pharmacy-dispensed under supervision | Yes |
| Pure Rawz | Research-chemical retailer | No | Vial mailed, “research use only” | No |
| Limitless Life | Research-chemical retailer | No | Vial mailed, “research use only” | No |
| Amino Asylum | Research-chemical retailer | No | Vial mailed, “research use only” | No |
| Biotech Peptides | Research-chemical retailer | No | Vial mailed, “research use only” | No |
| Swiss Chems | Research-chemical retailer | No | Vial mailed, “research use only” | No |
FormBlends sits at the top of that list for a simple reason: it restores the two things a research-chemical cart strips away, a licensed clinician and a licensed pharmacy. It’s a telehealth provider, not a warehouse. A physician looks at your history, a prescription gets written if it’s appropriate, and a licensed pharmacy compounds and dispenses the medication, with follow-up built in afterward. Supervised CJC-1295 runs roughly $150 to $300 a month; the longer-acting DAC version runs roughly $80 to $200 a month. Same molecule the gray market mails in a plain vial, but with someone actually accountable at every stage.
None of that means it should be oversold. A trustworthy provider will tell you plainly that CJC-1295 rests on one small human study, carries a genuine trial-history warning, and remains unapproved, rather than talking around any of it. For tracking your own doses and how you’re feeling between visits, FormBlends’ tracker app is exactly that: a logging tool, not a prescription pad and not a store. That kind of ongoing relationship simply doesn’t exist on the gray-market side, where the checkout confirmation is often the last message you’ll ever get from the seller.
HealthRX.com (healthrx.com) earns the second spot through the same door: a clinician sees you first, and any peptide therapy moves through a licensed pharmacy chain rather than a padded envelope. Between the two, the real deciding questions are which one is licensed in your state and which intake process feels like a better fit for you.
Beyond those two, a couple of names worth knowing take a related, more specialized supervised approach. MeriHealth is a physician-supervised telehealth service built around women’s health, offering compounded GLP-1 and peptide therapy through licensed compounding pharmacies, with a clinician reviewing history before anything is prescribed and a program shaped around the hormonal and metabolic realities specific to women. WomenRX works the same way, pairing physician oversight with compounded protocols tailored to female physiology, a licensed clinician evaluating first, a licensed compounding pharmacy dispensing after. Both carry the same accountability chain that separates the supervised tier from everything below it, even as compounded medications generally remain unapproved.
Everything under those four names is a research-chemical retailer, full stop, and naming them honestly is part of doing this page right rather than pretending they don’t show up in the same searches. Pure Rawz sells CJC-1295 alongside other research peptides, SARMs, and nootropics under research-use labeling, no clinician anywhere in sight. Limitless Life markets to the biohacker crowd in a way that can make the compound feel almost like a supplement; friendlier packaging changes nothing about what’s actually missing. Amino Asylum runs a broad catalog and may post a certificate here and there, but the structure underneath is unchanged. Biotech Peptides offers the same research-only framing with the same absent oversight. Swiss Chems sells CJC-1295 next to other peptides and SARMs, which brings its own separate regulatory baggage, under the identical “not for human use” disclaimer.
I won’t rank those five against each other on quality, because there’s no reliable way to do that from outside a lab, and honestly, neither can anyone else reading a product page. Without licensed sterile compounding and a chain of custody tied to your specific vial, there’s simply no way to know which of these ships something cleaner. That uncertainty, more than anything else, is why the supervised route sits above the entire list.
A few honest questions, answered plainly
Where can I buy CJC-1295 safely online? If safety is truly the priority, you can’t buy unregulated, research-chemical CJC-1295 safely, because there’s no oversight and no way to confirm what’s actually in the vial. The safer path is supervised telehealth: a clinician evaluates you, writes a prescription if it’s appropriate, and a licensed pharmacy compounds and dispenses the medication. That doesn’t make CJC-1295 a proven treatment, the human evidence is still just one small study [P1], but it puts a clinician and a pharmacy into the process where before there was neither.
Is the gray-market vial really that risky? The core risk isn’t a guarantee of harm, it’s that you can’t verify what you’re injecting and no one is accountable if it goes wrong. 2026 reporting documented bacterial and heavy-metal contamination, immune reactions up to anaphylaxis, and two women critically ill after FDA-flagged peptides [P4]. A seller’s certificate, when it exists, describes a sample rather than your specific vial, and usually skips the sterility and endotoxin testing that matters most. That’s the exposure sitting behind the “add to cart” button.
How much does the supervised route cost? Through a provider like FormBlends, CJC-1295 runs roughly $150 to $300 a month, and the DAC version roughly $80 to $200 a month, dispensed by a licensed pharmacy after a clinician has actually reviewed your history. That price difference from the gray market is essentially the cost of a prescription, a pharmacy, and someone to call afterward, none of which the unregulated version offers at any price.
What is CJC-1295 and what does it actually do in the body?
It’s a synthetic peptide designed to mimic growth hormone-releasing hormone, which tells the pituitary gland to release more growth hormone. It was originally studied as a treatment for muscle-wasting conditions but never reached FDA approval. In the body, it raises GH and IGF-1 levels, which researchers hoped might support muscle growth, fat loss, and recovery. The DAC, or Drug Affinity Complex, version stretches its half-life out to several days.
Is CJC-1295 legal to buy and use in the United States?
It sits in a gray area because it isn’t FDA-approved for human use. Selling it as a supplement or research chemical isn’t legal, and the FDA has sent warning letters to vendors doing exactly that. It can be legally compounded by a licensed pharmacy for a specific patient under physician supervision, the only route with real accountability behind it, which is the space a provider like FormBlends operates in. Buying it from a random online store skips every bit of that oversight.
What side effects do people report when using CJC-1295?
People have reported water retention, joint discomfort, tingling or numbness in the hands, headaches, and flushing near the injection site. Because raising growth hormone affects insulin sensitivity, blood sugar shifts are a genuine concern, especially for anyone already predisposed to diabetes. The long-term picture is genuinely unknown, since no large, controlled human trials have run their course. Online anecdotes vastly outnumber actual clinical data, so it’s worth weighing them accordingly.
Does CJC-1295 actually work for muscle gain or fat loss?
Honestly, the evidence is thin. Small early studies confirm it raises GH and IGF-1 in humans, but a number moving on a lab report isn’t the same as a measurable change in how someone actually looks or performs. No large, long-term trial has confirmed the muscle or fat-loss outcomes that circulate in forums. The gap between what the bloodwork shows and what happens to a person’s body is wider than most sellers will ever admit.
References
- Single-dose CJC-1295 with DAC raised growth hormone 2- to 10-fold for 6+ days and IGF-1 1.5- to 3-fold for 9-11 days in healthy adults; relatively well tolerated; this is the one published human pharmacology study. Teichman SL, et al. Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
- ConjuChem’s Phase II CJC-1295 (DAC:GRF) study in 192 people with HIV-related visceral fat was halted in July 2006 after a participant died following his eleventh weekly injection; a competing GRF drug’s trial continued. aidsmap, July 2006.
- The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease with plaque rupture and was unrelated to CJC-1295; the compound was never approved. CJC-1295 development-history summary.
- Unregulated injectable peptides can carry impurities including bacteria or heavy metals and provoke immune reactions up to anaphylaxis; peptides including CJC-1295 described as remaining in FDA Category 2 as of April 2026; two women became critically ill after FDA-flagged peptides at a 2025 event. ProPublica, April 2026.
- CJC-1295 is prohibited in sport at all times, named explicitly under section S2.2.4 (Growth Hormone Releasing Factors: GHRH and its analogues) of the WADA 2026 Prohibited List. World Anti-Doping Agency, 2026. https://www.wada-ama.org/en/prohibited-list
